SCHEIBLER LUKAS

CIK 00016512812 companiesSEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001651281

Recent Transactions

50 trades

Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-12-01$13.85/sh+10,000→ 78,299 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-12-01−10,000→ 39,391 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-12-01$60.00/sh−10,000→ 68,299 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-09-06$43.01/sh−1,756→ 68,299 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-02-21+14,023→ 14,023 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21$58.50/sh−715→ 69,643 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-21+9,886→ 70,358 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-02-10$51.21/sh−678→ 60,472 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-27$52.77/sh−542→ 61,150 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-20$52.05/sh−2,015→ 61,692 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2023-01-12+22,580→ 63,707 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2023-01-12$52.66/sh+35,472→ 35,472 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-05-27$43.00/sh−10,000→ 40,358 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-04-21−11,250→ 0 total
Other
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-21−1,875→ 50,358 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-04-05−609→ 49,391 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-05$60.09/sh−609→ 52,233 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-05$13.85/sh+609→ 52,842 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-04$56.86/sh−1,437→ 53,482 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-04$55.84/sh−818→ 54,919 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-04$57.80/sh−1,249→ 52,233 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-04$13.85/sh+3,504→ 55,737 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-04-04−3,504→ 50,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-01$55.05/sh−11,496→ 52,233 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-04-01−11,496→ 53,504 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-04-01$13.85/sh+11,496→ 63,729 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-14$26.73/sh+720→ 52,233 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-02-14−720→ 133,777 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-11$46.80/sh−1,666→ 51,513 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-02-10−10,000→ 65,000 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-10$50.00/sh−10,000→ 53,179 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-10$13.85/sh+10,000→ 63,179 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-10$47.12/sh−678→ 53,179 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-08$45.00/sh−10,000→ 53,857 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-02-08−10,000→ 75,000 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-02-08$13.85/sh+10,000→ 63,857 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-31$38.47/sh−1,233→ 53,857 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-28$38.59/sh−642→ 55,090 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-21+26,051→ 55,732 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-21+36,951→ 36,951 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2022-01-21$26.73/sh+3,021→ 29,681 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2022-01-21−3,021→ 134,497 total
Sale
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-06-10$60.00/sh−3,417→ 26,651 total
Tax Payment
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-02-10$47.72/sh−680→ 29,290 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-28+11,250→ 11,250 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2021-01-28+45,000→ 45,000 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-28+7,500→ 28,095 total
Award
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2021-01-28+1,875→ 29,970 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Common Stock
2020-12-08$26.73/sh+7,482→ 20,595 total
Exercise/Conversion
Apellis Pharmaceuticals, Inc.$APLS
Stock Option (Right to Buy)
2020-12-08−7,482→ 137,518 total

Companies

Recent Filings

Address

C/O ACUCELA INC. 1301 SECOND AVE., SUITE 4200

SEATTLE, WA, 98101

View on SEC.gov